Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
irlanda: clinical pharmacology and therapeutics,
irlande: clinical pharmacology and therapeutics
Last Update: 2014-10-23
Usage Frequency: 2
Quality:
reino unido: clinical pharmacology and therapeutics.
royaume-uni: clinical pharmacology and therapeutics
Last Update: 2014-10-23
Usage Frequency: 2
Quality:
1 coetzee y col, 2007, journal of veterinary pharmacology & therapeutics, 30, 4, 305-319.
1 coetzee et al, 2007, journal of veterinary pharmacology & therapeutics, 30, 4, 305-319.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
Warning: This alignment may be wrong.
Please delete it you feel so.
editor jefe, frontiers in psychopharmacology; editor asociado, neuropsychiatry; editor sobre el terreno, fundamental and clinical pharmacology.
directeur éditorial de frontiers in psycopharmacology; membre du comité éditorial de neuropsychiatry; rédacteur de terrain à fundamental and clinical pharmacology.
Last Update: 2017-01-02
Usage Frequency: 1
Quality:
coautora del libro "new knowledge of pharmacology of drugs " (nuevos conceptos sobre la farmacología de los estupefacientes), medicinska naklada, zagreb
coauteur du livre >, medicinska naklada, zagreb
Last Update: 2016-12-04
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
directrices definitivas • choice of control group in clinical trials (cpmp/ich/364/96), ich e10. • clinical investigation of medicinal products in children (cpmp/ich/2711/99), ich e11. • safety pharmacology studies for human pharmaceuticals (cpmp/ich/539/00), ich s7a. • stability testing guidelines: stability testing of new active substances and medicinal products (cpmp/ich/2736/99 rev. of cpmp/ich/380/95), ich q1ar. • non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals (cpmp/ich/286/95, modification), ich m3 modification. • reproductive toxicology: toxicity to male fertility (cpmp/ich/136/95 modification), ich s5b modification. • data elements for transmission of individual case safety reports (cpmp/ich/287/95 modification), ich e2b. • recommendations on electronic transmission of individual case safety reports message specification (cpmp/ich/285/95), ich m2. • good manufacturing practice guide for active pharmaceutical ingredients (cpmp/ich/4106/00), ich q7a. • common technical document (ctd) (cpmp/ich/2887/99), ich m4.
lignes directrices finales — choice of control group in clinical trials (cpmp/ich/364/96), ich e10 — clinical investigation of medicinal products in children (cpmp/ich/2711/99), ich e11 — safety pharmacology studies for human pharmaceuticals (cpmp/ich/539/00), ich s7a — stability testing guidelines: stability testing of new active substances and medicinal products (cpmp/ich/2736/99 rev. of cpmp/ich/380/95), ich q1ar — non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals (cpmp/ich/286/95, modification), ich m3 modification — reproductive toxicology: toxicity to male fertility (cpmp/ich/136/95 modification), ich s5b modification — data elements for transmission of individual case safety reports (cpmp/ich/287/95 modification), ich e2b — recommendations on electronic transmission of individual case safety reports message specification (cpmp/ich/285/95), ich m2 — good manufacturing practice guide for active pharmaceutical ingredients (cpmp/ich/4106/00), ich q7a — common technical document (ctd), (cpmp/ich/2887/99), ich m4
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.